Skip to main content

Krogulski Kenneth's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) · filed Apr 4, 2025

Accession no.
0001628280-25-016741
Filed
Apr 4, 2025
Trade date
Mar 3-31, 2025
Filing delay
32 daysLate
Rule 10b5-1 plan
Checked

This filing lists 21 non-derivative transactions and 0 derivative transactions. Open-market purchases total $4.55K. It was filed 32 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Krogulski KennethCIK 0001695580Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 3, 2025Common StockPPurchaseAcquired+47$5.54+$260.38282,890Direct
Mar 4, 2025Common StockPPurchaseAcquired+47$5.11+$240.17282,937Direct
Mar 5, 2025Common StockPPurchaseAcquired+47$6.75+$317.25282,984Direct
Mar 6, 2025Common StockPPurchaseAcquired+47$6.57+$308.79283,031Direct
Mar 7, 2025Common StockPPurchaseAcquired+47$6.51+$305.97283,078Direct
Mar 10, 2025Common StockPPurchaseAcquired+37$5.85+$216.45283,115Direct
Mar 11, 2025Common StockPPurchaseAcquired+37$4.85+$179.45283,152Direct
Mar 12, 2025Common StockPPurchaseAcquired+37$5.17+$191.29283,189Direct
Mar 13, 2025Common StockPPurchaseAcquired+37$5.47+$202.39283,226Direct
Mar 14, 2025Common StockPPurchaseAcquired+37$5.38+$199.06283,263Direct
Mar 17, 2025Common StockPPurchaseAcquired+37$5.41+$200.17283,300Direct
Mar 18, 2025Common StockPPurchaseAcquired+37$5.12+$189.44283,337Direct
Mar 19, 2025Common StockPPurchaseAcquired+37$5.41+$200.17283,374Direct
Mar 20, 2025Common StockPPurchaseAcquired+37$5.07+$187.59283,411Direct
Mar 21, 2025Common StockPPurchaseAcquired+37$4.89+$180.93283,448Direct
Mar 24, 2025Common StockPPurchaseAcquired+45$4.42+$198.9283,493Direct
Mar 25, 2025Common StockPPurchaseAcquired+45$4.45+$200.25283,538Direct
Mar 26, 2025Common StockPPurchaseAcquired+45$4.41+$198.45283,583Direct
Mar 27, 2025Common StockPPurchaseAcquired+45$4.20+$189283,628Direct
Mar 28, 2025Common StockPPurchaseAcquired+45$4.20+$189283,673Direct
Mar 31, 2025Common StockPPurchaseAcquired+45$4.29+$193.05283,718Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)